Dr. Raphael Bueno serves as the Chief of the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital in Boston, Massachusetts. Brigham and Women’s Hospital is one of the best mesothelioma medical centers in the world and Dr. Raphael Bueno is a top mesothelioma treatment doctor.
Dr. Bueno is a prominent mesothelioma figure with trailblazing research, treatment, and teachings. Raphael Bueno, MD, is a leader of the International Mesothelioma Program, a leading mesothelioma team that brings over 20 years of clinical and research experience to find a cure for this disease. Dr. Bueno has served as a mesothelioma specialist for over three decades and continues to make headways in the medical community.
Dr. Raphael Bueno currently serves as the Chief of the Division of Thoracic and Cardiac Surgery at Brigham and Women’s Hospital, a top medical center for mesothelioma. He is also the Co-Director of the BWH Heart and Vascular Center as well as the Lung Center. Dr. Bueno is the Vice Chairman of Surgery for Cancer and Translational Research and a Harvard Medical School professor. He serves as the senior surgeon at the Dana-Farber/BWH Cancer Center and Brigham and Women’s Faulkner Hospital. He is also a National Cancer Institute-funded investigator, meaning he pioneers research in thoracic surgery practice.
Dr. Bueno is an expert in identifying diagnostic markers for cancer, specifically mesothelioma and lung cancer. His clinical interests include:
Dr. Raphael Bueno led the BWH mesothelioma thoracic surgery team to Israel to perform the country’s first minimally invasive esophagectomies and teach surgeons how to perform them. In 2013, he performed the world’s first Image-guided Video-Assisted Thoracic Surgery (iVATS) procedure on a lung cancer patient. Boston Magazine and Castle Connolly have both awarded Dr. Bueno as a Top Doctor.
Dr. Bueno participates in several studies and is listed as an author of many important publications. These publications help top doctors pave the way for new mesothelioma and lung cancer discoveries.
Raphael Bueno took part in a publication regarding surgery for malignant pleural mesothelioma. Bueno, among other scientists, conducted the study to determine risk factors and prognosis for postoperative empyema after pleurectomy decortications for malignant pleural mesothelioma.
Dr. Bueno, among other scientists, cultivated this study to explore immune checkpoint inhibitors for non-small cell lung cancer. The study accumulated data on tumor response and surgical outcomes.
Scientists, including Dr. Raphael Bueno, established a publication reporting prognostic models for malignant pleural mesothelioma. The study concluded that doctors could utilize pretreatment parameters to evaluate the expected outcome of surgeries.
Dr. Bueno currently works at Brigham and Women’s Hospital in Boston, Massachusetts. You can find Dr. Bueno’s BWH office at 15 Francis Street in Boston, MA 02115. Raphael Bueno, MD, can be contacted by phone at (844) 294-5864 for specialized mesothelioma treatment.
If you are concerned about finding treatment or legal guidance, Mesothelioma Hub can assist you.
Madeline works for the patient advocate team and writes about asbestos exposure and mesothelioma. She is passionate about helping families in the mesothelioma community.
Beattie, R. (2021, December). Two centres experience of lung cancer resection in patients with advanced non-small cell lung cancer upon treatment with immune checkpoint inhibitors: safety and clinical outcomes. Retrieved from National Library of Medicine: https://pubmed.ncbi.nlm.nih.gov/34331065/
Brigham and Women’s Hospital. (2022). Raphael Bueno, MD. Retrieved from Brigham and Women’s Hospital: https://physiciandirectory.brighamandwomens.org/details/1303/raphael-bueno-thoracic_surgery-boston
BWH Research. (n.d.). Raphael Bueno, MD. Retrieved from BWH Research: http://www.bwhresearch.org/bri-centers/cancer-research-center/featured-investigators/bueno/
International Mesothelioma Program. (n.d.). Raphael Bueno, MD. Retrieved from International Mesothelioma Program: https://impmeso.org/the-imp-program/imp-leadership/raphael-bueno-md/
Lapidot, M. (2021, October). Postoperative Empyema After Pleurectomy Decortication for Malignant Pleural Mesothelioma. Retrieved from National Library of Medicine: https://pubmed.ncbi.nlm.nih.gov/34619137/
Yeap, B. (2021, November). Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma. Retrieved from National Library of Medicine: https://pubmed.ncbi.nlm.nih.gov/34242791/